BRD0209
BRD0209 is a potent, selective and dual inhibitor of GSK3α/β inhibitor (GSK3α IC50 = 19 nM; GSK3β IC50 = 5 nM) . BRD0209 is also a reversible ATP-competitive inhibitor with fast-off kinetics (Ki = 4.2 nM, respectively) . BRD0209 is a tricyclic pyrazolotetrahydroquinolinone compound. BRD0209 has the potential for the research of mood disorder diseases[1].
Product Specifications
CAS Number
1597439-87-6
UNSPSC
12352005
Hazard Statement
H302, H315, H319
Target
GSK-3
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR; Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/brd0209.html
Purity
99.63
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C1C2=C(N=C3C([C@]2(C)C4=CC=CC=C4)=C(C5CC5)NN3)CC(C)(C)C1
Molecular Formula
C22H25N3O
Molecular Weight
347.45
Precautions
H302, H315, H319
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
EGFR (Epidermal Growth Factor Receptor) (F4), Biotin conjugate, 0.1mg/mL
IKK alpha (CHUK) pSer180 (+IKKB pSer181) Rabbit Polyclonal Antibody
![DPYD Recombinant Rabbit Monoclonal Antibody [JE54-79]](https://cdn.genprice.uk/products/992/68dd1c8b061270361ea81663/imageurl/et7110-83.webp)